{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360004239691394816.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.3892/mco.2016.953"}},{"identifier":{"@type":"URI","@value":"https://spandidos-publications.com/10.3892/mco.2016.953/download"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"Primary tumor SUVmax on preoperative FDG-PET/CT is a prognostic indicator in stage IA2-IIB cervical cancer patients treated with radical hysterectomy"}],"description":[{"notation":[{"@value":"The objective of the present study was to investigate the prognostic value of 18F-fluoro-2-deoxy-D-glucose (FDG) uptake by primary tumors on positron emission tomography/computed tomography (PET/CT) in surgically resectable cervical cancer. A total of 59 patients with stage IA2-IIB cervical cancer who underwent preoperative FDG-PET/CT, followed by radical hysterectomy and lymphadenectomy, were included in the study. The maximum standardized uptake value (SUVmax) of the primary tumor was measured, and the association between the SUVmax and clinicopathological factors or patient outcomes was analyzed. The SUVmax was significantly higher in patients with an advanced stage, lymph node metastasis, lymph-vascular space involvement and large tumors. The overall survival (OS) and progression-free survival (PFS) of patients with a high SUVmax were significantly lower compared with patients with a low SUVmax, using an optimal cut-off value of 7.36 for OS and 5.59 for PFS obtained from receiver operating characteristic curve analysis. Similarly, OS and PFS in patients with a high SUVmax were significantly lower in 39 patients with stage IB using a cut-off value of 7.90 and 6.69 for OS and PFS, respectively. Finally, multivariate analyses showed that the SUVmax of the primary tumor was an independent prognostic factor for impaired PFS in all patients and those with stage IB alone. These findings demonstrated that a high SUVmax on preoperative PET/CT was correlated with unfavorable clinical outcomes in patients receiving radical hysterectomy, suggesting that the SUVmax of the primary tumor may be a prognostic indicator for surgically-treated, early-stage invasive cervical cancer."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380004239691394820","@type":"Researcher","foaf:name":[{"@value":"Shigetaka Yagi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004239691394945","@type":"Researcher","foaf:name":[{"@value":"Tamaki Yahata"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004239691394944","@type":"Researcher","foaf:name":[{"@value":"Yasushi Mabuchi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004239691394822","@type":"Researcher","foaf:name":[{"@value":"Yuko Tanizaki"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004239691394946","@type":"Researcher","foaf:name":[{"@value":"Aya Kobayashi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004239691394819","@type":"Researcher","foaf:name":[{"@value":"Michihisa Shiro"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004239691394818","@type":"Researcher","foaf:name":[{"@value":"Nami Ota"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004239691394816","@type":"Researcher","foaf:name":[{"@value":"Sawako Minami"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004239691394817","@type":"Researcher","foaf:name":[{"@value":"Masaki Terada"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004239691394821","@type":"Researcher","foaf:name":[{"@value":"Kazuhiko Ino"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"20499450"},{"@type":"EISSN","@value":"20499469"}],"prism:publicationName":[{"@value":"Molecular and Clinical Oncology"}],"dc:publisher":[{"@value":"Spandidos Publications"}],"prism:publicationDate":"2016-07-07","prism:volume":"5","prism:number":"3","prism:startingPage":"216","prism:endingPage":"222"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","url":[{"@id":"https://spandidos-publications.com/10.3892/mco.2016.953/download"}],"createdAt":"2016-07-07","modifiedAt":"2018-01-07","project":[{"@id":"https://cir.nii.ac.jp/crid/1040000782305749760","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"26462535"},{"@type":"JGN","@value":"JP26462535"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-26462535/"}],"notation":[{"@language":"ja","@value":"ケモカインと免疫抑制シグナル及び血管内皮前駆細胞との相互的な卵巣癌促進機構の解明"},{"@language":"en","@value":"Role of chemokine systems and its relation to immunotolerance and angiogenesis in ovarian cancer progression"}]},{"@id":"https://cir.nii.ac.jp/crid/1040282257296077056","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"26861338"},{"@type":"JGN","@value":"JP26861338"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-26861338/"}],"notation":[{"@language":"ja","@value":"卵巣癌におけるCX3CL1-CX3CR1システムの分子病態生理学的役割の解明"},{"@language":"en","@value":"Pivotal roles of CX3CL1-CX3CR1 systems in ovarian cancer progression"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360011145725926016","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Annual report of the <scp>C</scp>ommittee on <scp>G</scp>ynecologic <scp>O</scp>ncology, the <scp>J</scp>apan <scp>S</scp>ociety of <scp>O</scp>bstetrics and <scp>G</scp>ynecology"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011146176789376","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574094467264384","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Correlation between Biological Marker Expression and <sup>18</sup>F-Fluorodeoxyglucose Uptake in Cervical Cancer Measured by Positron Emission Tomography"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095390779648","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"FDG-PET/CT for diagnosis of primary ovarian cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846640216621952","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Preoperative risk stratification using metabolic parameters of 18F-FDG PET/CT in patients with endometrial cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846642687390848","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Diagnostic Value of Preoperative SUVmax on FDG-PET/CT for the Detection of Ovarian Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848659822636928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinicopathologic Factors of Cervical Adenocarcinoma Stages IB to IIB"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855568495729024","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855568937691648","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Management of cervical cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855569470504960","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Multimodality Therapy for Locally Advanced Cervical Carcinoma: State of the Art and Future Directions"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855569492947840","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Prognostic Value of the Metabolic Tumor Volume in FIGO stage IA to IIB Cervical Cancer for Tumor Recurrence: Measured by F-18 FDG PET/CT"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855569549498752","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Histopathologic parameters of prognosis in cervical cancer - a review"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137043717663232","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Correlation Between FDG Uptake by PET/CT and the Expressions of Glucose Transporter Type 1 and Hexokinase II in Cervical Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137044121967744","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Reconsideration of postoperative concurrent chemoradiotherapy with fluorouracil and cisplatin for uterine cervical cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418521372852864","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The standardized uptake value for F‐18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470338863232","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262945099599616","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Additional Prognostic Value of SUV<sub>max</sub> Measured by F-18 FDG PET/CT over Biological Marker Expressions in Surgically Resected Cervical Cancer Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544418450068224","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The predictive value of measurement of SUVmax and SCC-antigen in patients with pretreatment of primary squamous cell carcinoma of cervix"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544418735080064","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825893294803328","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prognostic significance of SUVmax (maximum standardized uptake value) measured by [18F]FDG PET/CT in endometrial cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825896139948672","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Nodal-staging surgery for locally advanced cervical cancer in the era of PET"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107368879125248","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Radical hysterectomy for FIGO stage I–IIB adenocarcinoma of the uterine cervix"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107369751986560","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388843306700032","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388844518706176","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Lymph Node Staging by Positron Emission Tomography in Cervical Cancer: Relationship to Prognosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388844665210368","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845370101632","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: Preliminary results"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670318709109504","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670319395996160","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Intratumoral Metabolic Heterogeneity of Cervical Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951796312132608","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prognostic Significance of Volume-Based Metabolic Parameters in Uterine Cervical Cancer Determined Using 18F-Fluorodeoxyglucose Positron Emission Tomography"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233270748085248","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1371695769308562950","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Adjuvant platinum-based chemotherapy for early stage cervical cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1371695769308563082","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The prognostic significance of pretreatment [18F]FDG-PET/CT imaging in patients with uterine cervical cancer: Preliminary results"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.3892/mco.2016.953"},{"@type":"KAKEN","@value":"PRODUCT-21090412"},{"@type":"KAKEN","@value":"PRODUCT-21136519"},{"@type":"OPENAIRE","@value":"doi_dedup___::079551e5709ebb2b2a91729c34a991e9"}]}